DEA Telemedicine Flexibilities Near Their December 31 End With the Final Rule Still at White House Review
DEA's final rule creating a special registration for telemedicine has been under OMB review since August 25, 2026, with a November target and no public text, while the temporary flexibilities that let practitioners prescribe Schedule II through V drugs to never-seen patients expire at the end of December 31.